Literature DB >> 30883620

Evaluation of a Newly Designed Microperforated Pure Titanium Membrane for Guided Bone Regeneration.

Hiroshi Hasegawa, Seiichiro Masui, Hiroshi Ishihata, Tetsuharu Kaneko, Daichi Ishida, Manabu Endo, Chihiro Kanno, Morio Yamazaki, Takehiro Kitabatake, Shinji Utsunomiya, Kenji Izumi, Keiichi Sasaki.   

Abstract

PURPOSE: This study aimed to evaluate the safety and efficacy of newly designed, laser-perforated pure titanium membranes for guided bone regeneration and to compare them with an existing product, the FRIOS BoneShield (FBS).
MATERIALS AND METHODS: Acute-type lateral ridge defects were bilaterally created in the mandibles of 13 dogs (two defects per animal). The defects were randomly divided into three groups and were reconstructed with particulate autologous bone (PAB) in combination with three different titanium membranes: (1) F001M0 (prototype without a frame), (2) F001M1 (prototype with a frame), and (3) FBS as a standard membrane. All animals were observed periodically and sacrificed 26 or 27 weeks postoperatively. At 26 weeks, approximately half of the dogs in each group underwent membrane removal to examine the postoperative condition of the titanium membranes. The samples were dissected and processed for radiographic, histologic, and histomorphometric analyses.
RESULTS: Membrane exposure was not found in the F001M0 or F001M1 groups, and their membranes were removed easily without adhesion to the surrounding tissue. Regenerated bone tissue volume was largest in the F001M1 group, followed by the F001M0 and FBS groups. A significant difference was observed only between the F001M1 and FBS groups (P = .047). In contrast, bone mineral density was similar among the three groups. Histologically, a layer of fibrous tissue was present underneath the titanium membrane, overlying the regenerated cortical bone in all the groups. Notably, the tissue was highly vascular in the F001M1 and F001M0 groups compared with the FBS group. In addition, there was little difference in the semiquantitative soft tissue evaluation and histologic findings of bone regeneration among the three groups. The histomorphometric analysis revealed that the regenerated bone area was larger in the F001M1 and F001M0 groups than in the FBS group, and a significant difference was observed only between the F001M1 and FBS groups (P = .045). Calcific osseous area was similar among the three groups.
CONCLUSION: The safety and efficacy of both F001M0 and F001M1 were equivalent to or greater than those of FBS, thereby indicating their potential for future clinical applications.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30883620     DOI: 10.11607/jomi.6777

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  4 in total

1.  Comparison of Macro-and Micro-porosity of a Titanium Mesh for Guided Bone Regeneration: An In Vivo Experimental Study.

Authors:  Motoki Senoo; Akira Hasuike; Takanobu Yamamoto; Yasumasa Ozawa; Norihisa Watanabe; Mitsuaki Furuhata; Shuichi Sato
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 2.  Titanium mesh for bone augmentation in oral implantology: current application and progress.

Authors:  Yu Xie; Songhang Li; Tianxu Zhang; Chao Wang; Xiaoxiao Cai
Journal:  Int J Oral Sci       Date:  2020-12-30       Impact factor: 6.344

3.  Evaluation of Preosteoblast MC3T3-E1 Cells Cultured on a Microporous Titanium Membrane Fabricated Using a Precise Mechanical Punching Process.

Authors:  Jingyu Zhang; Yukihiko Sakisaka; Hiroshi Ishihata; Kentaro Maruyama; Eiji Nemoto; Shigeki Chiba; Masaru Nagamine; Hiroshi Hasegawa; Satoru Yamada
Journal:  Materials (Basel)       Date:  2020-11-22       Impact factor: 3.623

4.  Hard tissue stability after guided bone regeneration: a comparison between digital titanium mesh and resorbable membrane.

Authors:  Songhang Li; Junyi Zhao; Yu Xie; Taoran Tian; Tianxu Zhang; Xiaoxiao Cai
Journal:  Int J Oral Sci       Date:  2021-11-16       Impact factor: 6.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.